LIPOFUNDIN MCT-LCT 20% INFUSION 500 ML BOTTLE

LIPOFUNDIN MCT-LCT 20% Infusion is an advanced intravenous lipid emulsion specifically designed to provide essential energy and fatty acids for patients requiring parenteral nutrition.

This sterile, pyrogen-free solution offers a balanced combination of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT), crucial for metabolic support when oral or enteral feeding is insufficient, contraindicated, or impossible.

Developed by B. Braun, a trusted name in pharmaceutical and medical supplies, Lipofundin ensures high-quality nutritional support for critically ill patients and those undergoing recovery.

Benefits of Use

• Provides concentrated caloric support for patients unable to receive sufficient nutrition orally or enterally.
• Supplies essential fatty acids (linoleic and alpha-linolenic acids) crucial for various physiological functions, including immune response and cell membrane integrity.
• Supports positive nitrogen balance when combined with amino acids and carbohydrates as part of a total parenteral nutrition regimen.
• Helps maintain fluid and electrolyte balance in the body, contributing to overall patient stability.
• Optimized lipid composition with MCTs for rapid energy utilization and LCTs for sustained energy and essential fatty acid supply.

How to Use

1. LIPOFUNDIN MCT-LCT 20% is administered intravenously, typically via a central venous catheter, under strict medical supervision.
2. The infusion rate and total dosage should be carefully determined by a healthcare professional based on the patient's age, weight, metabolic state, and specific energy and fatty acid requirements.
3. Ensure strict aseptic technique throughout the preparation and administration process to prevent contamination and potential infections.
4. Before use, visually inspect the bottle for any signs of damage, particulate matter, or phase separation. Do not use if any of these are present.
5. It is commonly administered as a component of a total parenteral nutrition regimen, often co-infused with amino acid solutions and glucose solutions.

Caution & Warnings

• Risk of hypersensitivity reactions; patients should be closely monitored, especially during the initial administration of the infusion.
• Use with extreme caution in patients with severe liver impairment, severe renal insufficiency, or known disorders of lipid metabolism (e.g., severe hyperlipidemia).
• Regular monitoring of serum triglyceride levels, blood glucose, electrolytes, fluid balance, and liver function tests is essential throughout the treatment period.
• Avoid rapid infusion, as this may lead to fat overload syndrome, characterized by symptoms such as fever, anemia, leukopenia, thrombocytopenia, and bleeding tendencies.
• Contraindicated in cases of acute shock, acute pulmonary embolism, severe hyperlipidemia, acute pancreatitis with hyperlipidemia, and known allergy to egg or soy proteins.
• This product is for intravenous administration only. It must not be administered by direct intramuscular or subcutaneous injection.
• Do not store partially used bottles. Discard any unused portion after initial opening to prevent microbial contamination.

Ingredients

• Medium-chain triglycerides
• Long-chain triglycerides (soybean oil, olive oil)
• Egg phospholipids (emulsifier)
• Glycerol (osmotic agent)
• Water for injections
• Sodium oleate (emulsifier stabilizer)

Product Details

• Formulation: Sterile, pyrogen-free lipid emulsion for infusion.
• Concentration: 20% (w/v) total lipids.
• Volume: 500 ml per glass bottle.
• Packaging: Clear glass bottle, designed for hospital and clinical use.
• Manufacturer: B. Braun Melsungen AG.